RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Medtronic on July 15 and set a price target of $101.00. The company’s shares closed yesterday at $89.78. Take advantage of TipRanks ...

The defect has resulted in problems including a procedural delay, difficulty removing device fragments and bleeding, the FDA said.

Leslie Holton was a graduate student studying virtual reality in medicine when her mother died of metastatic breast cancer.

The volunteer teams typically take two to four mission trips every year. Three missions are planned for 2025. Each trip involves prepping, packing, shipping and setting up an entire, functioning ...

Patients with heart failure and atrial fibrillation (AF) at the time of mitral transcatheter edge-to-edge repair (M-TEER) for ...

Medtronic has announced the first subject enrolment in the Peripheral Onyx Liquid Embolic (PELE) trial. The study aims to ...

Medtronic announced that the first patient has been enrolled in PELE, the Peripheral Onyx Liquid Embolic clinical trial. The inves ...

Medtronic (NYSE: MDT) today announced the first patient enrolled in the PELE trial of its Onyx liquid embolic system (LES).

Medtronic's Jason Fontana offers an update on next-generation Symplicity Spyral devices, procedures and a new feature they're ...

Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the Donald Trump administration's policies. Health care stocks can often be a solid defensive play in an ...

Japan-based Future offers specialty and workhorse guidewires. The agreement includes the first 400 cm, 0.018″ peripheral ...

Medtronic announced it has entered into an exclusive United States distribution agreement with Japan-based Future Medical Design C ...